Keyword: Astellas Pharma

Seattle Genetics

40. Padcev

Seattle Genetics and Astellas scored their approval for Padcev nearly three months early, but that quick OK didn’t surprise analysts, who pointed to high unmet need in metastatic bladder cancer.

The MELLODDY project

Short for Machine Learning Ledger Orchestration for Drug Discovery, the three-year project from the Innovative Medicines Initiative hopes to build an AI platform capable of ingesting large libraries of proprietary information while protecting its confidentiality.